日本小林制药社长和会长辞职，几十名消费者此前疑因服用该公司含红麹成分的保健品死亡。
彭博社报道，小林制药（Kobayashi Pharmaceutical Co.）星期二（7月23日）发布声明称，社长小林章浩及会长小林一雅将辞任，公司专务山根聪将接任社长一职。
小林制药上个月说，正在调查76人因服用含红麹成分保健品死亡的事件。红麹的学名为红麹霉，用于酿造红麹米酒和制作食品已有千余年的历史。
公司股价星期二在东京市场跌1％，今年累计跌幅近18%。
新华社引述日本卫生劳动部长武见敬三5月28日的话说，确认在小林制药公司含红麹成分的保健品原料中检测到的软毛青霉酸（puberulic acid）会对肾脏造成不良影响。除软毛青霉酸外，样品检测还确认了其他两种此前未知的化合物的存在。武见敬三说，推测这些物质都是在培养红麹的过程中混入的青霉菌所产生。
On September 14th, local time, US President Trump told reporters on his way back to Washington that he expected the Federal Reserve to announce a "significant interest rate cut" at its meeting this week, stating that "the current situation is very suitable for a rate cut."
On September 14th, local time, US President Trump told repo…
On September 12th, the 80th session of the United Nations G…
Recently, Reuters reported that Circa Biotech in Ain, Unite…
The UK and the US announced that they will sign a groundbre…
On September 14, the United States and the United Kingdom o…
On September 14th, the fourth round of high-level economic …
© Copyright 2025, All Rights Reserved
